About NEXT OncologyDeveloping The Next Breakthrough
Our mission is to transform the industry though the development of the next breakthrough in cancer research through high quality Phase 1 clinical pharmacology trials.
Your NEXT Option
NEXT Oncology, founded by Anthony W. Tolcher, M.D., FRCPC, is a Phase 1 center dedicated to providing options for advanced cancer patients and advancing cancer research. Dr. Tolcher’s passion for research and the community lays the foundation for an international brand committed to finding the next breakthrough.
Dr. Anthony Tolcher
Dr. Anthony Tolcher is a medical oncologist and co-founder of NEXT. He is dedicated to the development of new anticancer agents for patients whose current cancer therapy is no longer working to benefit them and are looking for their next option that includes clinical trials of new agents and therapies. Dr. Tolcher is proud that at NEXT Oncology the team scours the world to bring the best new agents back to our patients and centers.
This is not a job for Dr. Tolcher, it is his passion.
"We are going to make cancer treatable or curable in my lifetime." Read more from Dr. Tolcher in the recent article written by WOAI.